Trial Protocol GlobiFer - Oral Iron Repletion
NCT03055559 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 60
Last updated 2018-03-14
Summary
The haemoglobin level of the patients with iron deficiency should be increased clinical relevant after 12 weeks treatment with GlobiFer Forte.
Conditions
Interventions
- DIETARY_SUPPLEMENT
-
Globifer Forte
Sponsors & Collaborators
-
Gedeon Richter Slovakia, s.r.o.
lead OTHER
Principal Investigators
-
Ján Danko, PhD. · Comenius University's Jessenius Faculty of Medicine
Eligibility
- Min Age
- 18 Years
- Max Age
- 60 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2016-06-30
- Primary Completion
- 2017-05-04
- Completion
- 2017-05-04
Countries
- Slovakia
Study Locations
More Related Trials
-
Ferrous Sulphate Supplement (V0355) in Women With Iron Deficiency Anaemia
NCT02518568 ·Status: TERMINATED ·Phase: PHASE1
-
Extension Study of Iron Chelation Therapy With Deferasirox in β-thalassemia and Rare Chronic Anemia Patients
NCT00303329 ·Status: COMPLETED ·Phase: PHASE2
-
The Effectiveness of Lactoferrin in the Management of Treatment-induced Anemia
NCT03683810 ·Status: UNKNOWN ·Phase: PHASE1
-
A Phase 3, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Study of Fostamatinib Disodium in the Treatment of wAIHA
NCT03764618 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluate the PK, Safety, Tolerability of Ferric Maltol at 3 Dosage Levels in Paediatric Subjects With Iron Deficiency
NCT03181451 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Demonstrate the Efficacy and Tolerability of Ferrous Bisglycinate Chelate in Iron Deficiency Anaemia and to Compare These With Those of Ferrous Ascorbate.
NCT01160198 ·Status: COMPLETED ·Phase: PHASE3
-
Hypoferritinemia Without Anemia Among Reproductive Age Females
NCT06437080 ·Status: COMPLETED ·Phase: NA
-
Iron Balance Study of DFO and GT56-252 in Patients With Transfusional Iron Overload Secondary to Beta-Thalassemia
NCT00069862 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Randomized, Double-blind, Comparative Study of Intravenous Iron Isomaltoside 1000 (Monofer®) Against Placebo
NCT02172001 ·Status: WITHDRAWN ·Phase: PHASE3
-
An Extension Study of Iron Chelation Therapy With Deferasirox (ICL670) in β-thalassemia Patients With Transfusional Iron Overload
NCT00171210 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Oral Deferasirox (20 mg/kg/d) in Pts 3 to 6 Months After Allogeneic Hematopoietic Cell Transplantation Who Present With Iron Overload
NCT00654589 ·Status: COMPLETED ·Phase: PHASE4
-
IV Ferric Carboxymaltose Compared With Oral Iron in the Treatment of Iron Deficiency Anemia at Delivery in Tanzania
NCT02541708 ·Status: UNKNOWN ·Phase: PHASE3
-
Ferric Carboxymaltose Treatment to Improve Fatigue Symptoms in Iron-deficient Non-anaemic Women of Child Bearing Age
NCT01110356 ·Status: COMPLETED ·Phase: PHASE4
-
Bovine Lactoferrin to Prevent and Cure Iron Deficiency and Iron Deficiency Anemia in Complicated Pregnancies
NCT01221844 ·Status: COMPLETED ·Phase: PHASE4
-
Assessing the Immediate Increase in Serum Ferritin After Oral Iron Doses: an Experimental Study in Iron-deficient Women
NCT06851130 ·Status: RECRUITING ·Phase: NA
-
Improvement of Fatigue Symptoms in the Iron Deficiency Anemia With Iron Succinylate Therapy
NCT03873584 ·Status: WITHDRAWN
-
Effect of Iron Status on Occurrence of Non-transferrin-bound Iron (NTBI) in Serum in Response to an Oral Iron Load
NCT02831712 ·Status: UNKNOWN ·Phase: NA
-
IV Iron Safety: Evaluation of Iron Species in Healthy Subjects
NCT02399449 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluate the Safety and Efficacy of Ferric Maltol Oral Suspension vs. Ferrous Sulfate Oral Liquid in Children and Adolescents Aged 2 to 17 Years With Iron-deficiency Anaemia, With a Single Arm Study in Infants Aged 1 Month to Less Than 2 Years
NCT05126901 ·Status: COMPLETED ·Phase: PHASE3
-
The Optimization of Bioavailability From Iron Supplements: Study 2
NCT02177851 ·Status: COMPLETED ·Phase: NA
-
Intravenous Iron in paTients With Heart failURe and Reduced Ejection fracTion (HFREF) pLus Iron dEficiency
NCT03079518 ·Status: COMPLETED ·Phase: PHASE2
-
Iron Supplementation in Heart Failure Patients With Anemia: The IRON-HF Study
NCT00386126 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency / and Sub-Study
NCT03037931 ·Status: COMPLETED ·Phase: PHASE3
-
Incidence of Hypophosphatemia After Treatment With Iron Isomaltoside/Ferric Derisomaltose or Ferric Carboxymaltose in Subjects With Iron Deficiency Anaemia
NCT03237065 ·Status: COMPLETED ·Phase: PHASE3
-
A 4-year Extension Study to Core 1-year Study of Iron Chelation Therapy With Deferasirox in β-thalassemia Major Pediatric Patients With Transfusional Iron Overload.
NCT00390858 ·Status: COMPLETED ·Phase: PHASE2